Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.

Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma. Cancer. 2020 12 01; 126(23):5077-5087.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Dose-Response Relationship, Drug
Female
Hematopoietic Stem Cell Transplantation
Humans
Male
Melphalan
Middle Aged
Multiple Myeloma
Neoplasm Recurrence, Local
Transplantation, Autologous
Treatment Outcome
United States

authors with profiles

MUZAFFAR H QAZILBASH